Literature DB >> 32674646

Maternal mortality and COVID-19.

Maira L S Takemoto1, Mariane O Menezes1, Carla B Andreucci2, Roxana Knobel3, Liduína A R Sousa4, Leila Katz5, Eduardo B Fonseca6, Claudia G Magalhães1, Wanderson K Oliveira7, Jorge Rezende-Filho8, Adriana S O Melo9, Melania M R Amorim5.   

Abstract

OBJECTIVE: The aim of this study was to collect and analyze data from different sources to have a general overview of COVID-19-related maternal deaths in Brazil, as well as to compare data with worldwide reports. STUDY
DESIGN: We systematically searched data about COVID-19 maternal deaths from the Brazilian Ministry of Health surveillance system, State Departments of Health epidemiological reports, and media coverage. Data about timing of symptom onset and death (pregnancy or postpartum), gestational age, mode of birth, maternal age, comorbidities and/or risk factors, date of death, and place of death were retrieved when available.
RESULTS: We identified 20 COVID-19-related maternal deaths, age range 20-43 years. Symptoms onset was reported as on pregnancy for 12 cases, postpartum for 3 cases, and during the cesarean section for 1 case (missing data for 4). In 16 cases, death occurred in the postpartum period. At least one comorbidity or risk factor was present in 11 cases (missing data for 4). Asthma was the most common risk factor (5/11). Ten cases occurred in the Northeast region, and nine cases occurred in the Southeast region (5 of them in São Paulo, the first epicenter of COVID-19 in the country).
CONCLUSIONS: To the best of our knowledge, this is the largest available series of maternal deaths due to COVID-19. Barriers to access healthcare, differences in pandemic containment measures in the country and high prevalence of concomitant risk factors for COVID-19 severe disease may play a role in the observed disparity compared to worldwide reports on maternal outcomes.

Entities:  

Keywords:  COVID-19; coronavirus; maternal mortality; postpartum period; pregnancy; severe acute respiratory syndrome coronavirus 2

Mesh:

Year:  2020        PMID: 32674646     DOI: 10.1080/14767058.2020.1786056

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  18 in total

1.  Preeclampsia among women with COVID-19 during pregnancy and its impact on maternal and perinatal outcomes: Results from a national multicenter study on COVID in Brazil, the REBRACO initiative.

Authors:  José P Guida; Jose G Cecatti; Renato T Souza; Rodolfo C Pacagnella; Carolina C Ribeiro-do-Valle; Adriana G Luz; Giuliane J Lajos; Fernanda G Surita; Guilherme M Nobrega; Thayna B Griggio; Charles M Charles; Maria J Miele; Silvana B Ferreira; Ricardo P Tedesco; Karayna G Fernandes; Sérgio H A Martins-Costa; José G L Ramos; Frederico J A Peret; Francisco E Feitosa; Evelyn Traina; Edson V Cunha-Filho; Janete Vettorazzi; Samira M Haddad; Carla B Andreucci; Mário D Correa-Junior; Jussara Mayrink; Marcos A B Dias; Leandro G Oliveira; Elias F Melo-Junior; Marília G Q da Luz; Maria Laura Costa
Journal:  Pregnancy Hypertens       Date:  2022-05-10       Impact factor: 2.494

2.  Characteristics and outcomes of COVID-19 pneumonia in pregnancy compared with infected nonpregnant women.

Authors:  Maryam Vizheh; Salut Muhidin; Faezeh Aghajani; Zohreh Maleki; Fereshteh Bagheri; Hadiseh Hosamirudsari; Ashraf Aleyasin; Afsaneh Tehranian
Journal:  Int J Gynaecol Obstet       Date:  2021-04-19       Impact factor: 4.447

Review 3.  The Profile of the Obstetric Patients with SARS-CoV-2 Infection According to Country of Origin of the Publication: A Systematic Review of the Literature.

Authors:  Yolanda Cuñarro-López; Pilar Pintado-Recarte; Ignacio Cueto-Hernández; Concepción Hernández-Martín; María Pilar Payá-Martínez; María Del Mar Muñóz-Chápuli; Óscar Cano-Valderrama; Coral Bravo; Julia Bujan; Melchor Álvarez-Mon; Miguel A Ortega; Juan Antonio De León-Luis
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

Review 4.  A Comprehensive Analysis of Maternal and Newborn Disease and Related Control for COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-03-17

Review 5.  Immunological and physiopathological approach of COVID-19 in pregnancy.

Authors:  Raquel Ferrer-Oliveras; Manel Mendoza; Sira Capote; Laia Pratcorona; Enrique Esteve-Valverde; Lluis Cabero-Roura; Jaume Alijotas-Reig
Journal:  Arch Gynecol Obstet       Date:  2021-05-04       Impact factor: 2.344

6.  Spatial clusters, social determinants of health and risk of maternal mortality by COVID-19 in Brazil: a national population-based ecological study.

Authors:  Thayane Santos Siqueira; José Rodrigo Santos Silva; Mariana do Rosário Souza; Débora Cristina Fontes Leite; Thomas Edwards; Paulo Ricardo Martins-Filho; Ricardo Queiroz Gurgel; Victor Santana Santos
Journal:  Lancet Reg Health Am       Date:  2021-09-10

Review 7.  Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.

Authors:  David A Schwartz; Denise Morotti
Journal:  Viruses       Date:  2020-11-15       Impact factor: 5.048

8.  Routine screening for SARS CoV-2 in unselected pregnant women at delivery.

Authors:  Pilar Díaz-Corvillón; Max Mönckeberg; Antonia Barros; Sebastián E Illanes; Arturo Soldati; Jyh-Kae Nien; Manuel Schepeler; Javier Caradeux
Journal:  PLoS One       Date:  2020-09-29       Impact factor: 3.240

9.  Clinical features of pregnant women in Iran who died due to COVID-19.

Authors:  Soheila Amini Moghadam; Parisa Dini; Setare Nassiri; Mahtab Motavaselian; Marzieh Hajibaba; Masoudreza Sohrabi
Journal:  Int J Gynaecol Obstet       Date:  2020-12-02       Impact factor: 4.447

10.  Clinical characteristics and risk factors for mortality in obstetric patients with severe COVID-19 in Brazil: a surveillance database analysis.

Authors:  Mls Takemoto; M O Menezes; C B Andreucci; R Knobel; L Sousa; L Katz; E B Fonseca; M Nakamura-Pereira; C G Magalhães; Csg Diniz; Aso Melo; Mmr Amorim
Journal:  BJOG       Date:  2020-09-14       Impact factor: 7.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.